SynCav

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameSynCav
Drug Alias Nameneurodegenerative diseases gene therapy (Raft Therapeutics)
ClassificationBiologics
Mechanisms of ActionCaveolin-1 stimulants
TargetsCaveolin-1
Therapy Area/IndicationsNerve Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRaft Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRaft Therapeutics
Active IndicationsN/A
Inactive IndicationsNerve Degeneration

Other Information

ATC CodeN/A
Related LinksN/A